NCT05141721 2025-05-16
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
Seattle Project Corporation
Phase 2/3 Active not recruiting
Clinical Trials
8 trialsNCT03158610 2021-05-03
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer
Ruijin Hospital
Phase 2/3 Terminated
NCT00212615 2020-11-06
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
Odense University Hospital
Phase 2/3 Completed
NCT00647530 2019-05-17
FOxTROT
University of Birmingham
Phase 2/3 Unknown
NCT01196260 2018-02-20
Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III
State Key Laboratory of Cancer Biology
Phase 2/3 Unknown
NCT02893540 2016-09-16
Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC
Ruijin Hospital
Phase 2/3 Unknown
NCT01097265 2013-08-12
Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2/3 Unknown
NCT00294359 2007-08-22
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group
Phase 2/3 Completed